GPT and hepatocellular carcinoma: The ALT levels were normalized in 65.6% at 1 year and in 81.9% at 2 years and were related to a significantly lower HCC risk as determined through landmark (p < 0.001) and time-dependent Cox analyses (adjusted odds ratio 0.57; p < 0.001).